Pulmonary function has been studied in Parkinsonism, including idiopathic Parkinson's disease.'"3 Most studies were performed in the 1960s and were hampered by the fact that Parkinson's disease was not clearly separated from (post)-encephalitic Parkinson- medication which might result in pulmonary dysfunction, known structural abnormalities of the upper airways including oral cavity and dementia severe enough to interfere with pulmonary testing.
All patients were scored using Hoehn and Yahr,5 Webster and Northwestern University Disability Scale (NUDS)' (see table 1 ). In addition age, age at onset of disease, principal symptom (tremor or rigidity) and medication were recorded.
All patients were on levodopa-substitution therapy. Furthermore all patients used anticholinergic drugs and some amantadine as well. Medication was not changed during at least one month prior to testing. The neurological parameters of all patients, including those who suffered from response fluctuations, were scored immediately before testing.
Pulmonary function testing All patients were subjected to spirography (Lode D 53/R, the Netherlands) which resulted in a measure of vital capacity (VC) and forced expiratory volume in 1 s (FEVy). Always at least three attempts were made and the best result was used. A maximal expiratory and maximal inspiratory flow-curve (MEFV and MIFV) could be obtained in 28 patients. Of the remaining three, one patient could only produce a MEFVcurve, while the results in the two other patients were not reliable. The flow-volume curve relates maximal expiratory and inspiratory flows to displaced volume at the mouth from total lung capacity and residual volume during expiration and inspiration respectively. A normal example is given in fig 1 
there is a trend for most parameters to decrease from group III to V. Vital capacity, forced inspiratory volume in 1 s and the ratio of forced expiratory volume in I s and vital capacity are relatively normal.
Twenty eight patients could produce a flow-volume curve. Four patients had a type A curve and 16 had type B, according to the classification ofVincken et al4 (see Discussion and fig 2) . Three pulmonary function parameters can be regarded as indicators of upper airway obstruction (see also Discussion): peak inspiratory flow, the ratio of forced expiratory volume in 1 s and peak expiratory flow and the ratio of the maximal expiratory and inspiratory flow at 50%. Nine patients had an abnormal value for one of these parameters, eight patients for two and only one for all three parameters.
Several significant correlations (r) could be demonstrated between the neurological disability scores (Webster and NUDS) or the length of illness and the results ofthe pulmonary function test. They will not be given here as all r-values are rather small. They all (i(IS) 331 Another kind of abnormality is the significant low value of maximal expiratory flow at 50%. This parameter is relatively independent of muscle strength'2 and can be attributed to UAO. Vincken et al 'mainly used the following criteria, for UAO: ratio of forced expiratory volume in 1 s and peak expiratory flow (FEVY/PEF) > 8 5 ml per litre per minute, ratio of maximal expiratory and inspiratory flow at 50% (MEF50/MIF50) > 1 and peak inspiratory flow (PIF) < 3 litres per second. These three criteria represent different aspects of an extrathoracic upper airway obstruction.
In the presence ofsuch an obstruction, flow remains relatively small during the first part of the forced expiration. This results in a low peak expiratory flow (PEF). The integrated flow during the first second of forced expiration is much less sensitive to changes in PEF, which leads to a nearly normal forced expiratory volume in 1 s (FEV1).'3 The net result is an increased FEVI/PEF ratio.
Inspiration leads to a lowering of the intraluminal pressure at the site of an obstruction. Since the obstruction is not anatomically fixed, this leads to an increase of the obstruction: maximal inspiratory flow Hovestadt, Bogaard, Meerwaldt, van der Meche, Stigt at 50% (MIF50) decreases. The reverse process during expiration leads to an increased maximal expiratory flow at 50% (MEF50). The MEF50/MIF50 ratio is therefore increased to UAO. The same mechanism leads to a relatively low peak inspiratory flow during forced inspiration.
Because of the complex interactions of the mechanisms leading to these disturbances and the interindividual variation which is already present in normal controls, the definition of UAO is in a certain way arbitrary. When one ignores one abnormal score, nine of our patients have two or more abnormal scores and can thus be considered to have signs of UAO.
The mentioned criteria can be considered as quantitative indices of UAO. The pattern of the flowvolume-curves can give a qualitative indication whether or not an UAO is present. Vincken et al4 have classified for this purpose the curves into three types (see fig 2) : 1. Normal type 2. Type A. This consists basically of a normal pattern with superimposed de-and accelerations of the flow, either regular or irregular, which can be traced to tremor. Although the overall pattern is normal, often also lowered maximal flows are found. 3. Type B, which consists basically of a rounding off of the expiratory phase and a delayed appearance of the peak. In addition irregular flow changes occur frequently in the inspiratory phase.
In our group 82% of those with an abnormal curve had type B (n = 16), while only 22% of Vincken et al's patients had this type and 78% type A. This discrepancy is probably caused by patient selection because a large proportion oftheir patients had tremor as a prominent symptom and also patients with only essential tremor were included.
The rounding of and the delayed appearance of the peak of type B can be explained by a decrease of the maximal effort, necessary for the flow-volume curve, and by UAO. The values for the effort dependent peak expiratory and inspiratory flow, as discussed above, are significantly below normal. Although this decrease can also be explained by UAO, the occurrence of this pattern also in cases with only a slightly lowered peak expiratory and inspiratory flow and the absence of a marked plateau in the curves points to "muscle weakness" as the basic mechanism. The markedly lowered maximal static mouth pressures at residual volume and total lung capacity provide additional evidence. Also hypokinesia will play a role in that it will lead to a less explosive effort and so cause a shift of the peak appearance to lower volume levels.
In our group four patients had a type A curve and all four had two abnormal parameters of the three discussed above (PIF, FEVl/PEF, MEF50/MIF50).
This supports the concept of Schiffmann'4 and Vincken et al,4 that a type A curve is indicative of
